We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · June 03, 2021

Trametinib Safety and Efficacy in Non–V600 BRAF–Mutant Melanoma

The Oncologist


Additional Info

The Oncologist
Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase I Study
Oncologist 2021 Apr 16;[EPub Ahead of Print], CA Nebhan, DB Johnson, RJ Sullivan, RN Amaria, KT Flaherty, JA Sosman, MA Davies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading